TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ilika plc ( (GB:IKA) ) just unveiled an update.
Ilika plc, in partnership with Cirtec Medical, has achieved a significant milestone in the production of its Stereax micro-batteries, completing the manufacturing process qualification at Cirtec’s US facility. This advancement marks the beginning of production for product testing and initial customer deliveries, enhancing miniaturization capabilities for implantable medical devices. The collaboration combines Ilika’s advanced battery technology with Cirtec’s manufacturing expertise, positioning both companies to meet the growing demand for miniaturized medical implants.
Spark’s Take on GB:IKA Stock
According to Spark, TipRanks’ AI Analyst, GB:IKA is a Neutral.
Ilika plc’s overall stock score reflects significant financial challenges and a concerning valuation, balanced by positive developments in corporate events and strategic product advancements. The company’s ability to secure funding and progress with its technology provides some optimism, but the financial and valuation concerns weigh heavily on the score.
To see Spark’s full report on GB:IKA stock, click here.
More about Ilika plc
Ilika is a global expert in the development of solid-state battery technology for electric vehicles, medical devices, and consumer appliances. The company offers two product lines: Stereax batteries for miniature medical implants and IoT applications, and Goliath large format batteries for EVs and cordless appliances. Ilika operates through a licensing business model, providing its IP portfolio to OEMs and manufacturing partners.
Average Trading Volume: 215,224
Technical Sentiment Signal: Buy
Current Market Cap: £77.38M
For a thorough assessment of IKA stock, go to TipRanks’ Stock Analysis page.